Golotimod is an orally bioavailable synthetic peptide containing the amino acids D-glutamine and L-tryptophan connected by a gamma-glutamyl linkage with potential immunostimulating, antimicrobial and antineoplastic activities.
CAT No: 10-101-250
CAS No: 229305-39-9
Chemical Name: (R)-2-amino-5-(((S)-1-carboxy-2-(1H-indol-3-yl)ethyl)amino)-5-oxopentanoic acid
Quick InquiryCustom Peptide SynthesisRegistration of APIs CMC information required for an IND
IND and NDA support Drug master files (DMF) filing
Synonyms/Alias | Golotimod;229305-39-9;SCV-07;Golotimod [USAN];gamma-D-Glu-L-trp;SCV07;gamma-D-Glutamyl-L-tryptophan;SCV 07;Golotimod [USAN:INN];H-D-Glu(Trp-OH)-OH;GOLOTIMOD [INN];GOLOTIMOD [WHO-DD];(2R)-2-amino-5-[[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]amino]-5-oxopentanoic acid;637C487Y09;L-Tryptophan, D-gamma-glutamyl-;DTXSID10177474;D-.GAMMA.-GLUTAMYL-L-TRYPTOPHAN;(R)-2-Amino-5-(((S)-1-carboxy-2-(1H-indol-3-yl)ethyl)amino)-5-oxopentanoic acid;(2R)-2-Amino-5-(((1S)-1-carboxy-2-(1H-indol-3-yl)ethyl)amino)-5-oxopentanoic acid;golotimodum;(2R)-2-amino-4-(((1S)-1-carboxy-2-(1H-indol-3-yl)ethyl)carbamoyl)butanoic acid;(2R)-2-AMINO-4-{[(1S)-1-CARBOXY-2-(1H-INDOL-3-YL)ETHYL]CARBAMOYL}BUTANOIC ACID;UNII-637C487Y09;MFCD28137704;Golotimod (SCV-07);Golotimod (USAN/INN);Golotimod (SCV-07)?;H-D-Glu(L-Trp-OH)-OH;(gamma-glutamyl-L-tryptophan);SCHEMBL727944;CHEMBL2103812;DTXCID3099965;CATMPQFFVNKDEY-YPMHNXCESA-N;CHEBI:177459;BCP24651;D-GAMMA-GLUTAMYL-L-TRYPTOPHAN;EX-A10956;NSC755401;AKOS030573318;DB05475;NSC-755401;FG108327;HY-14743;MS-25023;DB-230492;CS-0003532;NS00068645;D08928;G14394;Q27095684;H-D-Glu(L-Trp-OH)-OH;SCV 07;gamma-D-Glu-L-trp;SCV-07;SCV07;(2R)-2-amino-5-[[(1S)-2-hydroxy-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-5-oxo-pentanoic acid; |
M.F/Formula | C16H19N3O5 |
M.W/Mr. | 333.34 |
Sequence | One Letter Code:XW Three Letter Code:H-D-gGlu-Trp-OH |
Appearance | White solid powder |
Purity | >98% |
Long-term Storage Conditions | Soluble in DMSO, not in water |
InChI | InChI=1S/C16H19N3O5/c17-11(15(21)22)5-6-14(20)19-13(16(23)24)7-9-8-18-12-4-2-1-3-10(9)12/h1-4,8,11,13,18H,5-7,17H2,(H,19,20)(H,21,22)(H,23,24)/t11-,13+/m1/s1 |
InChI Key | CATMPQFFVNKDEY-YPMHNXCESA-N |
Canonical SMILES | O=C(O)[C@H](N)CCC(N[C@H](C(O)=O)CC1=CNC2=C1C=CC=C2)=O |
2. Myotropic activity of allatostatins in tenebrionid beetles
5. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us. We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com